mannose binding lectin

Recombinant proteinexperimental

Mannose-binding lectin (MBL), also called mannan-binding lectin or mannan-binding protein (MBP), is a lectin that is instrumental in innate immunity as an opsonin and via the lectin pathway. — Wikipedia

Clinical trial activity

5 trials · 9 clinical orgs · 0 marketing orgs

Phase 1
4
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Apr 1, 2004 (NCT00138736)

Timeline

2000s

  1. Jan 1, 2004

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2006

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • mannose binding lectin
  • mannose-binding lectin

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT00520325Phase 1Jun 1, 2007Enzon, National Cancer Institute (NCI), National Institutes of Health (NIH)
NCT00415311Phase 1Dec 1, 2006Enzon, University of Nebraska
NCT00886496Phase 1Nov 1, 2006Enzon, National Cancer Institute (NCI)
NCT00388999Phase 1Sep 1, 2006Enzon, Hoosier Cancer Research Network
NCT00138736Phase 2Apr 1, 2004Landsteiner Foundation Blood Research (LSBR), Amsterdam, Medical Center Leeuwarden, Republican Endocrinology Center Hospital, Minsk, Republic of Belarus, Sanquin
Showing 5 of 5 trials
Page 1 / 1

Organizations

Research & Development (9)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
EnzonFor profit4412006
National Cancer Institute (NCI)Government2012006
Hoosier Cancer Research NetworkAcademic/Hospital1012006
Landsteiner Foundation Blood Research (LSBR), AmsterdamAcademic/Hospital1012004
Medical Center LeeuwardenAcademic/Hospital1012004
National Institutes of Health (NIH)Government1012007
Republican Endocrinology Center Hospital, Minsk, Republic of BelarusAcademic/Hospital1012004
SanquinAcademic/Hospital1112004
University of NebraskaAcademic/Hospital1012006
9 organizations
Page 1 / 1